AzTrials
AzTrials

Pain SyndromeNCT06141902

The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors

A study testing Jing Si Herbal Drink in people with Pain Syndrome and Emotional Stress, run by Buddhist Tzu Chi General Hospital at 1 site in Taiwan.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This study aim to explore the impact of Jing Si Herbal Tea on pain and emotional stress in peripheral blood stem cell donors. Read more about this study

Who is it for?
Ages 20 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Pain Syndrome, Emotional Stress
What is being tested?
Jing Si Herbal Drink
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTaiwan
Study dates
18 Sep 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • health Men or women aged 20 to 55 years old
  • willing to take Jing Si Herbal Drink

Who cannot join

  • no willing to take Jing Si Herbal Drink;
  • Previously already take Jing Si Herbal Drink daily

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site
  • Hualiien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    Hualien City, 970

Other trials in Taiwan

About this study

This study aim to explore the impact of Jing Si Herbal Tea on pain and emotional stress in peripheral blood stem cell donors.

Being tested
Jing Si Herbal Drink
Medical subject headings
Somatoform Disorders, Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jing Si Herbal DrinkOther

    Jing Si Herbal Drink

Study groups in NCT06141902
Study groupRoleWhat they receive
NORMALOtherdaily diet
Receives: Other: Jing Si Herbal Drink
Take Jing Si Herbal DrinkNo interventionTake Jing Si Herbal Drink daily

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in pain assessed by questionnaires

    For each of the pain sites includes: headache、bone、joint \& muscle, indicate the severity of present using the following scale (baseline vs. follow-up).

    grade 0: fully active, able to carry on all pre-disease performance without restriction

    grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work

    grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours

    grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours

    grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair

    grade 5: dead

    Measured: 5 day

Secondary outcomes (1)
  1. Changes in anxiety assessed by questionnaires

    Difference in donor Health State Trait Anxiety Index (STAI) scores (baseline vs. follow-up).

    The STAI questionnaire consists of 20 items for assessing "state anxiety" and 20 items for assessing "trait anxiety," with a raw score of 20 to 60 points for each scale.

    The state anxiety scale evaluates the current state of anxiety associated with a special situation, measuring subjective feelings of apprehension, tension, nervousness, worry, and activation of the autonomic nervous system, whereas the trait anxiety scale evaluates proneness to anxiety .

    The level of anxiety was determined according to the percentile rank obtained using the raw score of each questionnaire and was classified as low anxiety (1st-23th percentile), moderate anxiety (25th75th percentile) and high anxiety (77th-99th percentile).

    Measured: 21 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2023
  2. Study start18 Sep 2025 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06141902
Sponsor's protocol ID
IRB111-125-A
Other IDs
IMAR-111-01-17
Status last verified
Oct 2024
First submitted
5 Nov 2023
Last updated
19 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Jing Si Herbal Drink in people with Pain Syndrome and Emotional Stress, run by Buddhist Tzu Chi General Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in pain assessed by questionnaires (time frame: 5 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in